Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $387,164 - $498,628
-835 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $1,049 - $1,470
2 Added 0.24%
835 $470,000
Q4 2021

Mar 11, 2022

SELL
$708.84 - $794.68 $3,544 - $3,973
-5 Reduced 0.6%
833 $629,000
Q3 2021

Nov 15, 2021

BUY
$657.71 - $825.77 $3,946 - $4,954
6 Added 0.72%
838 $625,000
Q2 2021

Aug 16, 2021

BUY
$576.64 - $649.04 $1,729 - $1,947
3 Added 0.36%
832 $536,000
Q1 2021

May 17, 2021

SELL
$547.01 - $662.35 $3,282 - $3,974
-6 Reduced 0.72%
829 $473,000
Q4 2020

Feb 16, 2021

BUY
$510.68 - $643.45 $27,066 - $34,102
53 Added 6.78%
835 $487,000
Q3 2020

Nov 16, 2020

BUY
$454.43 - $535.6 $4,089 - $4,820
9 Added 1.16%
782 $403,000
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $258,854 - $381,135
773 New
773 $349,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.9B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.